A Unified Patent Court (UPC) is expected to officially open its doors in Europe in late 2022 or early 2023. The UPC is a patent‑specific court established by 24 participating European Union (EU) member states, with the goal...more
The Federal Circuit recently affirmed a district court’s determination, holding a group of patents invalid for indefiniteness.
In December 2014, HZNP Medicines LLC (“Horizon”) brought suit against Actavis Laboratories UT,...more
11/11/2019
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Generic Drugs ,
Indefiniteness ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Summary Judgment